PNC Financial Services Group
ABEO icon

PNC Financial Services Group’s Abeona Therapeutics ABEO Stock Holding History

PNC Financial Services Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$385 Buy
86
+81
+1,620% +$405 ﹤0.01% 4968
2025
Q4 		$26 Sell
5
-477
-99% -$2.4K ﹤0.01% 5123
2025
Q3 		$2.54K Buy
+482
New +$3.06K ﹤0.01% 4436

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PNC Financial Services Group's ABEO Position: Q1 2026 in Review

PNC Financial Services Group increased its Abeona Therapeutics (ABEO) stake by 1,620% in Q1 2026, buying an estimated $405 and bringing the position to 86 shares worth $385. The position accounts for ﹤0.01% of the portfolio, ranked #4968.

PNC Financial Services Group first reported a position in ABEO in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.54K in Q3 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • PNC Financial Services Group held 86 shares of Abeona Therapeutics worth $385 as of Q1 2026.
  • PNC Financial Services Group bought 81 Abeona Therapeutics shares in Q1 2026, an estimated $405.
  • Abeona Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4968 holding.
  • PNC Financial Services Group first reported a position in Abeona Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • PNC Financial Services Group's Abeona Therapeutics position peaked at $2.54K in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.